- Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI
- New approach to the development of non-opioid painkillers
- More than half of U.S. adults now eligible for statins under new guidelines
- Many countries overusing powerful antibiotics
- GLP-1 diabetes drugs linked to increased risk of hair loss
- Study reveals structure of brain protein and identifies potential drug target for epilepsy research
- A secret weapon against superbugs
- Researchers clear two major hurdles for minimally invasive cancer therapy
- AI platform could speed peptide drug discovery
- Starving bacteria to death
- Cutting-edge drug shows promise for patients with NRAS-driven melanoma
- Development of a novel "degraders" for the selective elimination of cancer cells
- RAS inhibitor daraxonrasib demonstrates initial anti-tumor activity in pancreatic cancer
- OPTAR opens a new route to first-in-class drug targets
- Cutting-edge drug shows promise for patients with NRAS-driven melanoma
- GLP-1 shows promise for patients with advanced fatty liver disease
- A deep dive into drug delivery
- Researchers create new path to target hard-to-drug prostate cancer protein
- Could an investigational drug that targets DNA damage help treat Alzheimer's disease?
- Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients with B-cell ALL
Website: https://www.worldpharmanews.com/
